Crystalvue Medical Corporation (TPEX:6527)
Taiwan · Delayed Price · Currency is TWD 76.80
+0.50 (0.66%)
Jan 22, 2026, 1:18 PM CST
Crystalvue Medical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 139.27 | 127.15 | 103.4 | 115.03 | 77.24 | 56.62 | Upgrade |
Depreciation & Amortization | 17.86 | 27 | 28.09 | 25.37 | 40.34 | 24.91 | Upgrade |
Other Amortization | 2.22 | 2.35 | 1.09 | 0.79 | 0.54 | 0.49 | Upgrade |
Loss (Gain) From Sale of Assets | -0.28 | - | - | - | -13.95 | - | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | - | - | 0.02 | Upgrade |
Stock-Based Compensation | - | 3.88 | 19.91 | - | - | - | Upgrade |
Other Operating Activities | -2.41 | -5.94 | -5.59 | 4.17 | 6.45 | 6.01 | Upgrade |
Change in Accounts Receivable | -10.22 | -62.85 | 36.55 | -50.42 | -13.33 | -17.48 | Upgrade |
Change in Inventory | -13.46 | 26.11 | -29.2 | -61.17 | -37.63 | 0.11 | Upgrade |
Change in Accounts Payable | 1.28 | 21.06 | 0.45 | 16.56 | -20.19 | 27.41 | Upgrade |
Change in Unearned Revenue | -3.31 | 1.63 | 1.47 | 1.31 | 6.94 | -0.47 | Upgrade |
Change in Other Net Operating Assets | 9.74 | 12.67 | -2.14 | 0.13 | 16.84 | -14.08 | Upgrade |
Operating Cash Flow | 140.7 | 153.06 | 154.01 | 51.76 | 63.26 | 83.54 | Upgrade |
Operating Cash Flow Growth | -15.52% | -0.62% | 197.53% | -18.17% | -24.28% | -14.43% | Upgrade |
Capital Expenditures | -242.24 | -130.44 | -4.37 | -7.52 | -351.17 | -29.77 | Upgrade |
Sale (Purchase) of Intangibles | -1 | -1.6 | -4.18 | -1.49 | 68.37 | -73.78 | Upgrade |
Investment in Securities | -3.01 | - | 0.17 | -0.59 | - | -85.46 | Upgrade |
Other Investing Activities | 1.7 | 3.41 | -0.75 | 5.08 | 88.88 | 4.03 | Upgrade |
Investing Cash Flow | -244.27 | -128.63 | -9.12 | -4.52 | -193.91 | -184.98 | Upgrade |
Long-Term Debt Repaid | - | -6.57 | -6.38 | -6.2 | -6.03 | -5.86 | Upgrade |
Net Debt Issued (Repaid) | -6.71 | -6.57 | -6.38 | -6.2 | -6.03 | -5.86 | Upgrade |
Issuance of Common Stock | - | 2.73 | 15.05 | - | - | - | Upgrade |
Repurchase of Common Stock | - | - | - | -11.97 | - | -21.04 | Upgrade |
Common Dividends Paid | -57.02 | -52.3 | -56.76 | -46.3 | -33.41 | -61.9 | Upgrade |
Financing Cash Flow | -63.73 | -56.13 | -48.09 | -64.47 | -39.44 | -88.8 | Upgrade |
Net Cash Flow | -167.3 | -31.71 | 96.8 | -17.23 | -170.09 | -190.24 | Upgrade |
Free Cash Flow | -101.53 | 22.62 | 149.64 | 44.24 | -287.91 | 53.77 | Upgrade |
Free Cash Flow Growth | - | -84.89% | 238.26% | - | - | -41.83% | Upgrade |
Free Cash Flow Margin | -11.21% | 2.61% | 18.16% | 5.56% | -39.90% | 10.66% | Upgrade |
Free Cash Flow Per Share | -3.94 | 0.88 | 5.92 | 1.73 | -11.35 | 2.10 | Upgrade |
Cash Interest Paid | 0.5 | 0.63 | 0.82 | 1 | 1.17 | 1.34 | Upgrade |
Cash Income Tax Paid | 31.63 | 38.17 | 21.94 | 23.24 | 25.48 | 0.34 | Upgrade |
Levered Free Cash Flow | -135.89 | -13 | 115.66 | 7.49 | -226.8 | -49.89 | Upgrade |
Unlevered Free Cash Flow | -135.57 | -12.61 | 116.17 | 8.12 | -226.07 | -49.05 | Upgrade |
Change in Working Capital | -15.97 | -1.38 | 7.12 | -93.59 | -47.36 | -4.51 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.